Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc Oxide Versus Petrolatum Following Skin Surgery
NCT03561376Phase 1Recruiting
- Start
- Sep 2021
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-blind, single-arm trial of zinc oxide in scar and surgical wound. Primary endpoints: Patient and Observer Scar Assessment Scale at 6 months, Percentage of epidermal linear seal at 4 weeks and 2 more. Started Sep 2021; status: recruiting.
02
Drugs
zinc oxide
03
Conditions
scarsurgical wound
Beyond the preview
Go deeper on NCT03561376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03561376.